NeoGenomics (NEO) Competitors

Globant (NYSE:GLOB) and NeoGenomics (NASDAQ:NEO) are both computer and technology companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, valuation, dividends, community ranking, media sentiment, risk, profitability and institutional ownership.

Does the MarketBeat Community favor GLOB or NEO?

NeoGenomics received 111 more outperform votes than Globant when rated by MarketBeat users. Likewise, 70.85% of users gave NeoGenomics an outperform vote while only 59.79% of users gave Globant an outperform vote.

Company	Underperform	Outperform
Globant	Outperform Votes 397 59.79%	Underperform Votes 267 40.21%
NeoGenomics	Outperform Votes 508 70.85%	Underperform Votes 209 29.15%

Does the media favor GLOB or NEO?

In the previous week, Globant had 10 more articles in the media than NeoGenomics. MarketBeat recorded 17 mentions for Globant and 7 mentions for NeoGenomics. Globant's average media sentiment score of 1.01 beat NeoGenomics' score of 0.99 indicating that Globant is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Globant	11 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
NeoGenomics	5 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has more risk and volatility, GLOB or NEO?

Globant has a beta of 1.5, indicating that its stock price is 50% more volatile than the S&P 500. Comparatively, NeoGenomics has a beta of 1.41, indicating that its stock price is 41% more volatile than the S&P 500.

Which has higher earnings and valuation, GLOB or NEO?

Globant has higher revenue and earnings than NeoGenomics. NeoGenomics is trading at a lower price-to-earnings ratio than Globant, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Globant	$2.42B	2.17	$158.54M	$3.72	32.07
NeoGenomics	$660.57M	1.97	-$87.97M	-$0.62	-16.35

Is GLOB or NEO more profitable?

Globant has a net margin of 6.86% compared to NeoGenomics' net margin of -11.92%. Globant's return on equity of 11.83% beat NeoGenomics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Globant	6.86%	11.83%	8.09%
NeoGenomics	-11.92%	-2.10%	-1.17%

Do analysts rate GLOB or NEO?

Globant currently has a consensus price target of $205.88, suggesting a potential upside of 72.57%. NeoGenomics has a consensus price target of $19.30, suggesting a potential upside of 90.34%. Given NeoGenomics' stronger consensus rating and higher possible upside, analysts plainly believe NeoGenomics is more favorable than Globant.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Globant	0 Sell rating(s)	5 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.69
NeoGenomics	0 Sell rating(s)	2 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.80

Do insiders & institutionals have more ownership in GLOB or NEO?

91.6% of Globant shares are held by institutional investors. Comparatively, 98.5% of NeoGenomics shares are held by institutional investors. 2.7% of Globant shares are held by company insiders. Comparatively, 1.3% of NeoGenomics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Globant beats NeoGenomics on 13 of the 18 factors compared between the two stocks.